Latest Pulmonology Articles

• Small-Bowel Bleeding April 25, 2024
  Abdominal pain and large-volume hematochezia developed in a man who was in the hospital for a ruptured cerebral aneurysm. Findings on endoscopy and colonoscopy were unremarkable, so CT angiography was performed.
  Zongli Han, Yanli Du
• Alectinib in Resected ALK-Positive Non–Small-Cell Lung Cancer April 11, 2024
  In a trial of adjuvant treatment for patients with resected ALK-positive non–small-cell lung cancer, disease-free survival at 2 years was 93.6% with the ALK inhibitor alectinib and 63.7% with standard chemotherapy.
  Yi-Long Wu, Rafal Dziadziuszko, Jin Seok Ahn, Fabrice Barlesi, Makoto Nishio, Dae Ho Lee, Jong-Seok Lee, Wenzhao Zhong, Hidehito Horinouchi, Weimin Mao, Maximilian Hochmair, Filippo de Marinis, M. Rita Migliorino, Igor Bondarenko, Shun Lu, Qun Wang, Tania Ochi Lohmann, Tingting Xu, Andres Cardona, Thorsten Ruf, Johannes Noe, Benjamin J. Solomon, the ALINA Investigators*
• Adjuvant Alectinib in ALK-Rearranged NSCLC — Here and Now April 11, 2024
  In 2009, the groundbreaking Iressa Pan-Asia Study (IPASS)1 showed the activity of gefitinib, a first-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI), and marked a pivotal shift in the treatment of advanced non–small-cell lung cancer (NSCLC) toward precision medicine. The trial highlighted the importance of identifying...
  Antonio Passaro, Solange Peters